Records 1-4 (of 4 Records) |
Query Trace: Wiskott Aldrich syndrome[original query] |
---|
Vaccination against respiratory tract pathogens in primary immune deficiency patients receiving immunoglobulin replacement therapy. Bayrak Durmaz Makbule Seda, et al. Tuberkuloz ve toraks 2024 0 0. (1) 1-8 |
WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Wang Ping-Yuan, et al. Proceedings of the National Academy of Sciences of the United States of America 2023 0 0. (34) e2302738120 |
Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report. Bradley Rachel E, et al. Journal of clinical immunology 2021 0 0. |
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report. Cenciarelli Sabina, et al. Frontiers in immunology 2020 0 0. 603428 |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: